Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

René Holm; Lone Bruun

Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

René Holm (Inventor), Lone Bruun (Inventor)

Research output: Patent

Abstract

The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.

Original language	English
IPC	A61K 31/ 554 A I
Patent number	US2014194409
Country/Territory	Denmark
Priority date	20/06/2012
Priority number	US201214126499
Publication status	Published - 10. Jul 2014
Externally published	Yes

Cite this

@misc{6b13610c561b4298a6ce65853b7d46df,

title = "Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia",

abstract = "The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.",

author = "Ren{\'e} Holm and Lone Bruun",

year = "2014",

month = jul,

day = "10",

language = "English",

type = "Patent",

note = "US2014194409; A61K 31/ 554 A I",

}

TY - PAT

T1 - Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

AU - Holm, René

AU - Bruun, Lone

PY - 2014/7/10

Y1 - 2014/7/10

N2 - The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.

AB - The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.

M3 - Patent

M1 - US2014194409

ER -

Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

Abstract

Fingerprint

Cite this